368 related articles for article (PubMed ID: 22316512)
1. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
[TBL] [Abstract][Full Text] [Related]
2. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
[TBL] [Abstract][Full Text] [Related]
3. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
5. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
7. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
9. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
[TBL] [Abstract][Full Text] [Related]
10. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
[TBL] [Abstract][Full Text] [Related]
11. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
[TBL] [Abstract][Full Text] [Related]
13. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
14. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
[TBL] [Abstract][Full Text] [Related]
15. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
16. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
[TBL] [Abstract][Full Text] [Related]
17. Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis.
Milojevic B; Djokic M; Sipetic-Grujicic S; Milenkovic-Petronic D; Vuksanovic A; Bumbasirevic U; Vukovic I; Dragicevic D; Tulic C
BJU Int; 2012 Apr; 109(7):1037-42. PubMed ID: 21883837
[TBL] [Abstract][Full Text] [Related]
18. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
[TBL] [Abstract][Full Text] [Related]
19. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
